Victory Capital Management Inc Emergent Bio Solutions Inc. Transaction History

Victory Capital Management Inc

$95.7 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$7.79 - $16.29 $757,429 - $1.58 Million	-97,231 Reduced 57.85%	70,837 $733,000
Q4 2022 Feb 10, 2023	BUY	$11.0 - $21.45 $41,052 - $80,051	3,732 Added 2.27%	168,068 $1.98 Million
Q4 2022 Feb 09, 2023	BUY	$11.0 - $21.45 $1.12 Million - $2.18 Million	101,707 Added 162.4%	164,336 $1.94 Million
Q3 2022 Nov 02, 2022	BUY	$20.09 - $35.8 $551,591 - $982,924	27,456 Added 78.06%	62,629 $1.32 Million
Q2 2022 Aug 01, 2022	BUY	$27.42 - $43.63 $69,235 - $110,165	2,525 Added 7.73%	35,173 $1.09 Million
Q1 2022 May 04, 2022	BUY	$36.48 - $52.22 $406,824 - $582,357	11,152 Added 51.88%	32,648 $1.06 Million
Q4 2021 Feb 07, 2022	BUY	$33.11 - $55.01 $21,753 - $36,141	657 Added 3.15%	21,496 $934,000
Q3 2021 Nov 02, 2021	BUY	$50.07 - $66.05 $32,946 - $43,460	658 Added 3.26%	20,839 $1.04 Million
Q2 2021 Aug 03, 2021	SELL	$56.61 - $80.46 $1.41 Million - $2 Million	-24,910 Reduced 55.24%	20,181 $1.27 Million
Q1 2021 May 04, 2021	BUY	$86.23 - $125.19 $2.65 Million - $3.85 Million	30,787 Added 215.23%	45,091 $4.19 Million
Q4 2020 Feb 01, 2021	SELL	$79.17 - $111.47 $1.84 Million - $2.6 Million	-23,302 Reduced 61.96%	14,304 $1.28 Million
Q3 2020 Nov 09, 2020	SELL	$81.91 - $134.94 $236,801 - $390,111	-2,891 Reduced 7.14%	37,606 $3.89 Million
Q2 2020 Aug 07, 2020	BUY	$54.33 - $89.52 $1.81 Million - $2.99 Million	33,381 Added 469.1%	40,497 $3.2 Million
Q1 2020 May 04, 2020	SELL	$49.34 - $68.76 $270,432 - $376,873	-5,481 Reduced 43.51%	7,116 $412,000
Q4 2019 Feb 06, 2020	BUY	$51.21 - $59.06 $270,337 - $311,777	5,279 Added 72.14%	12,597 $680,000
Q4 2019 Feb 04, 2020	SELL	$51.21 - $59.06 $279,606 - $322,467	-5,460 Reduced 42.73%	7,318 $403,000
Q3 2019 Nov 12, 2019	BUY	$40.6 - $57.2 $518,786 - $730,901	12,778 New	12,778 $668,000
Q3 2018 Nov 01, 2018	SELL	$52.05 - $66.51 $302,358 - $386,356	-5,809 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$48.33 - $55.64 $38,567 - $44,400	798 Added 15.92%	5,809 $293,000
Q1 2018 May 04, 2018	SELL	$44.44 - $54.39 $6,710 - $8,212	-151 Reduced 2.93%	5,011 $264,000
Q4 2017 Feb 01, 2018	BUY	$37.77 - $47.75 $16,883 - $21,344	447 Added 9.48%	5,162 $240,000
Q3 2017 Oct 27, 2017	BUY	$34.14 - $40.45 $160,970 - $190,721	4,715	4,715 $191,000

Others Institutions Holding EBS

# of Institutions

172

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account